A smoking cessation intervention for people with severe mental illness treated in ambulatory mental health care (KISMET): study protocol of a randomised controlled trial

被引:0
作者
Kucukaksu, Muege H. [1 ,2 ]
van Meijel, Berno [3 ,4 ,5 ,6 ]
Jansen, Lola [1 ,2 ]
Hoekstra, Trynke [1 ,2 ]
Adriaanse, Marcel C. [1 ,2 ]
机构
[1] Vrije Univ Amsterdam, Dept Hlth Sci, Van der Boechorststr 7, NL-1081 BT Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Fac Sci, Van der Boechorststr 7, NL-1081 BT Amsterdam, Netherlands
[3] Amsterdam UMC, Dept Psychiat, Amsterdam, Netherlands
[4] Amsterdam Publ Hlth Res Inst, Amsterdam, Netherlands
[5] Inholland Univ Appl Sci, Dept Hlth Sports & Welf, Boelelaan 1109, NL-1081 HV Amsterdam, Netherlands
[6] Parnassia Psychiat Inst, The Hague, Netherlands
关键词
Severe mental illness; Smoking cessation; Intervention; Pharmacological treatment; Behavioural counselling; Peer support; Randomised controlled trial; LIFE-STYLE; BIPOLAR DISORDER; SOCIAL NETWORK; SCHIZOPHRENIA; SMOKERS; RECRUITMENT; MAINTENANCE; RELIABILITY; DISPARITIES; DEPENDENCE;
D O I
10.1186/s12888-023-04599-x
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
BackgroundSmoking among people with severe mental illness (SMI) is highly prevalent and strongly associated with poor physical health. Currently, evidence-based smoking cessation interventions are scarce and need to be integrated into current mental health care treatment guidelines and clinical practice. Therefore, the present study aims to evaluate the implementation and effectiveness of a smoking cessation intervention in comparison with usual care in people with SMI treated by Flexible Assertive Community Treatment (FACT) teams in the Netherlands.MethodsA pragmatic, cluster-randomised controlled trial with embedded process evaluation will be conducted. Randomisation will be performed at the level of FACT teams, which will be assigned to the KISMET intervention or a control group (care as usual). The intervention will include pharmacological treatment combined with behavioural counselling and peer support provided by trained mental health care professionals. The intervention was developed using a Delphi study, through which a consensus was reached on the core elements of the intervention. We aim to include a total of 318 people with SMI (aged 18-65 years) who smoke and desire to quit smoking. The primary outcome is smoking status, as verified by carbon monoxide measurements and self-report. The secondary outcomes are depression and anxiety, psychotic symptoms, physical fitness, cardiovascular risks, substance use, quality of life, and health-related self-efficacy at 12 months. Alongside the trial, a qualitative process evaluation will be conducted to evaluate the barriers to and facilitators of its implementation as well as the satisfaction and experiences of both patients and mental health care professionals.DiscussionThe results of the KISMET trial will contribute to the evidence gap of effective smoking cessation interventions for people treated by FACT teams. Moreover, insights will be obtained regarding the implementation process of the intervention in current mental health care. The outcomes should advance the understanding of the interdependence of physical and mental health and the gradual integration of both within the mental health care system.
引用
收藏
页数:11
相关论文
共 66 条
  • [1] Ali R, 2002, ADDICTION, V97, P1183
  • [2] Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial
    Anthenelli, Robert M.
    Benowitz, Neal L.
    West, Robert
    St Aubin, Lisa
    McRae, Thomas
    Lawrence, David
    Ascher, John
    Russ, Cristina
    Krishen, Alok
    Evins, A. Eden
    [J]. LANCET, 2016, 387 (10037) : 2507 - 2520
  • [3] Egocentric social networks and smoking among adults with serious mental illness
    Aschbrenner, Kelly A.
    Bobak, Carly
    Schneider, Emily J.
    Naslund, John A.
    Brunette, Mary F.
    O'Malley, A. James
    [J]. TRANSLATIONAL BEHAVIORAL MEDICINE, 2018, 8 (04) : 531 - 539
  • [4] Qualitative analysis of social network influences on quitting smoking among individuals with serious mental illness
    Aschbrenner, Kelly A.
    Naslund, John A.
    Gill, Lydia
    Hughes, Terence
    O'Malley, Alistair J.
    Bartels, Stephen J.
    Brunette, Mary F.
    [J]. JOURNAL OF MENTAL HEALTH, 2019, 28 (05) : 475 - 481
  • [5] Social predictors of cessation treatment use among smokers with serious mental illness
    Aschbrenner, Kelly A.
    Ferron, Joelle C.
    Mueser, Kim T.
    Bartels, Stephen J.
    Brunette, Mary F.
    [J]. ADDICTIVE BEHAVIORS, 2015, 41 : 169 - 174
  • [6] BALKE B, 1963, Rep Civ Aeromed Res Inst US, P1
  • [7] Smoking cessation in severe mental illness: what works?
    Banham, Lindsay
    Gilbody, Simon
    [J]. ADDICTION, 2010, 105 (07) : 1176 - 1189
  • [8] Pragmatic Replication Trial of Health Promotion Coaching for Obesity in Serious Mental Illness and Maintenance of Outcomes
    Bartels, Stephen J.
    Pratt, Sarah I.
    Aschbrenner, Kelly A.
    Barre, Laura K.
    Naslund, John A.
    Wolfe, Rosemarie
    Xie, Haiyi
    McHugo, Gregory J.
    Jimenez, Daniel E.
    Jue, Ken
    Feldman, James
    Bird, Bruce L.
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2015, 172 (04) : 344 - 352
  • [9] Blankers M, 2015, J NEUROTRAUM
  • [10] Patterns of tobacco-related mortality among individuals diagnosed with schizophrenia, bipolar disorder, or depression
    Callaghan, Russell C.
    Veldhuizen, Scott
    Jeysingh, Trincy
    Orlan, Chloe
    Graham, Candida
    Kakouris, Gwen
    Remington, Gary
    Gatley, Jodi
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2014, 48 (01) : 102 - 110